We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Medicine & public health

Search Results

Showing 1-3 of 3 results

  1. The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma

    Background

    Mantle cell lymphoma (MCL) is an incurable B cell-derived malignant tumor with a median overall survival of 4–5 years. Mer tyrosine kinase...

    Cunzhen Shi, **angqun Li, ... Jun Zhu in Journal of Hematology & Oncology
    Article Open access 20 March 2018

  2. Interleukin 37 limits monosodium urate crystal-induced innate immune responses in human and murine models of gout

    Background

    Interleukin (IL)-37 has emerged as a fundamental inhibitor of innate immunity. Acute gout is a self-limiting inflammatory response to...

    Lei Liu, Yu Xue, ... Hejian Zou in Arthritis Research & Therapy
    Article Open access 18 November 2016

  3. Key Roles of AXL and MER Receptor Tyrosine Kinases in Resistance to Multiple Anticancer Therapies

    A major challenge in anticancer treatment is the pre-existence or emergence of resistance to therapy. AXL and MER are two members of the TAM...

    Marie Schoumacher, Mike Burbridge in Current Oncology Reports
    Article Open access 01 March 2017
Did you find what you were looking for? Share feedback.